Abstract
Introduction: Several data suggest that liver fibrosis is a dynamic process and fibrosis or even early stage of cirrhosis is not irreversible and cellular recovery is possible. Aim of our study was to investigate the effect of pegylated interferon alpha plus ribavirin (P/R) treatment on liver fibrosis progression in patients with chronic HCV hepatitis (CHC).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
